Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
Buturović-Ponikvar
J
J
Department of Nephrology, University Medical Center, Ljubljana, Slovenia.
Kandus
A
A
Malovrh
M
M
Ponikvar
R
R
Kveder
R
R
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use*; D006084:Graft Rejection / Q000628:therapy; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D015774:Ganciclovir; D008775:Methylprednisolone